Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Amanda Guo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Gut|July 11, 2022
Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilitiesShamaine Wei Ting Ho, Taotao Sheng, Manjie Xing, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
Gut|August 26, 2021
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibitionRaghav Sundar, Kie-Kyon Huang, Vikrant Kumar, et al.
Gut|March 14, 2023
Comprehensive molecular phenotyping of <i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunitiesChang Xu, Kie Kyon Huang, Jia Hao Law, et al.
The Journal of Clinical Investigation|May 5, 2020
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Wen Fong Ooi, Jing Tan, et al.
Cell Reports. Medicine|April 5, 2025
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerShumei Chia, Justine Jia Wen Seow, Rafael Peres da Silva, et al.
Nature Genetics|June 30, 2022
Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancerIgnasius Joanito, Pratyaksha Wirapati, Nancy Zhao, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Gut|July 11, 2022
Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilitiesShamaine Wei Ting Ho, Taotao Sheng, Manjie Xing, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
Gut|August 26, 2021
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibitionRaghav Sundar, Kie-Kyon Huang, Vikrant Kumar, et al.
Gut|March 14, 2023
Comprehensive molecular phenotyping of <i>ARID1A</i>-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunitiesChang Xu, Kie Kyon Huang, Jia Hao Law, et al.
The Journal of Clinical Investigation|May 5, 2020
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Wen Fong Ooi, Jing Tan, et al.
Cell Reports. Medicine|April 5, 2025
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerShumei Chia, Justine Jia Wen Seow, Rafael Peres da Silva, et al.
Nature Genetics|June 30, 2022
Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancerIgnasius Joanito, Pratyaksha Wirapati, Nancy Zhao, et al.
Pageof 2